Publisher
Springer Nature Singapore
Reference101 articles.
1. Albrecht MT, Li H, Williamson ED, LeButt CS, Flick-Smith HC, Quinn CP, Westra H, Galloway D, Mateczun A, Goldman S, Groen H, Baillie LW (2007) Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against bacillus anthracis infection and enhance endogenous immunity to anthrax. Infect Immun 75(11):5425–5433. https://doi.org/10.1128/iai.00261-07
2. Aydintug MK, Gu Y, Philipp MT (1994) Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey. Infect Immun 62(11):4929–4937. https://doi.org/10.1128/iai.62.11.4929-4937.1994
3. Baer M, Sawa T, Flynn P, Luehrsen K, Martinez D, Wiener-Kronish JP, Yarranton G, Bebbington C (2009) An engineered human antibody fab fragment specific for Pseudomonas aeruginosa PcrV antigen has potent antibacterial activity. Infect Immun 77(3):1083–1090. https://doi.org/10.1128/iai.00815-08
4. Bandaru A, Devalraju KP, Paidipally P, Dhiman R, Venkatasubramanian S, Barnes PF, Vankayalapati R, Valluri V (2014) Phosphorylated STAT3 and PD-1 regulate IL-17 production and IL-23 receptor expression in mycobacterium tuberculosis infection. Eur J Immunol 44(7):2013–2024. https://doi.org/10.1002/eji.201343680
5. Baxter LT, Zhu H, Mackensen DG, Jain RK (1994) Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice. Cancer Res 54(6):1517–1528